Icu Medical Inc/De Income Statement

Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 228.97M282.96M302.19M316.87M313.72M309.26M341.67M379.37M1,292.61M1,400.04M1,266.21M1,271.00M1,316.31M2,280.00M2,259.13M2,382.05M
Cost of Revenue 122.69M153.99M159.84M160.36M158.98M157.86M160.87M177.97M866.52M830.01M794.34M809.51M824.82M1,582.24M1,519.25M1,557.26M
Gross Profit 106.28M128.97M142.35M156.51M154.73M151.40M180.80M201.40M426.10M570.03M471.86M461.50M491.49M697.76M739.87M824.78M
Operating items
Research & Development 2.65M4.68M8.59M10.63M12.41M18.33M15.71M12.96M51.25M52.87M48.61M42.95M47.50M92.98M85.34M88.61M
Selling, General & Administrative 68.20M76.64M85.29M84.60M89.01M88.94M83.22M89.43M302.17M320.00M276.98M283.95M302.58M608.35M606.69M638.76M
Restructuring Costs 1.37M5.09M8.45M15.35M78.00M105.40M80.60M28.41M18.04M71.42M41.26M59.84M
Other Operating Expenses 14.24M1.09M0.73M7.97M62.00M-41.69M8.03M0.13M-32.09M-16.25M-5.40M
Operating Expenses 70.85M81.31M77.13M95.23M102.78M112.36M112.23M118.46M439.39M540.27M364.50M363.33M368.25M740.66M717.05M781.82M
Operating Income 35.43M47.66M65.22M61.28M51.95M39.04M68.56M82.94M-13.29M29.76M107.36M98.16M123.25M-42.90M22.82M42.96M
EBIT 35.43M47.66M65.22M61.28M51.95M39.04M68.56M82.94M-13.29M29.76M107.36M98.16M123.25M-42.90M22.82M42.96M
Non-operating items
Other Non Operating Income 1.46M70.90M
Non Operating Income 1.18M0.13M1.20M0.56M0.77M0.76M1.17M0.89M-4.27M-6.67M7.90M-2.59M-2.04M-5.14M-5.91M-13.22M
Net income details
EBT 36.61M47.78M66.42M61.84M52.71M39.79M69.70M85.16M51.28M22.37M114.71M97.49M123.19M-114.41M-78.30M-66.01M
Tax Provisions 11.63M17.86M21.75M20.56M12.30M13.46M24.71M22.08M-17.36M-6.42M13.67M10.62M20.05M-40.12M-48.64M51.68M
Profit After Tax 36.61M47.78M66.42M61.84M52.71M39.79M44.98M63.08M68.64M28.79M101.03M86.87M103.14M-74.29M-29.66M-117.69M
Income from Continuing Operations 24.98M29.92M44.67M41.28M40.42M26.34M44.98M63.08M68.64M28.79M101.03M86.87M103.14M-74.29M-29.66M-117.69M
Consolidated Net Income 24.98M29.92M44.67M41.28M40.42M26.34M44.98M63.08M68.64M28.79M101.03M86.87M103.14M-74.29M-29.66M-117.69M
Income towards Parent Company 24.98M29.92M44.67M41.28M40.42M26.34M44.98M63.08M68.64M28.79M101.03M86.87M103.14M-74.29M-29.66M-117.69M
Net Income towards Common Stockholders 24.98M29.92M44.67M41.28M40.42M26.34M44.98M63.08M68.64M28.79M101.03M86.87M103.14M-74.29M-29.66M-117.69M
Additional items
EPS (Basic) 1.702.203.232.902.751.722.843.903.501.414.904.164.86-3.11-1.23-4.83
EPS (Weighted Average and Diluted) 1.672.163.152.802.651.682.733.663.291.334.694.024.74-3.11-1.23-4.83
Shares Outstanding (Weighted Average) 14.81M13.59M13.83M14.59M14.73M15.37M15.98M16.33M20.13M20.49M20.67M20.98M21.24M23.98M24.14M24.48M
Shares Outstanding (Diluted Average) 14.98M13.86M14.16M14.72M15.27M15.65M16.50M17.25M20.86M21.60M21.55M21.59M21.78M23.87M24.09M24.39M
EBITDA 35.43M47.66M65.22M61.28M51.95M39.04M68.56M82.94M-13.29M29.76M107.36M98.16M123.25M-42.90M22.82M42.96M
Interest Expenses 0.04M0.12M2.05M0.71M0.55M1.75M0.86M
Tax Rate 31.76%37.38%32.75%33.24%23.33%33.82%35.46%25.93%11.92%10.90%16.28%35.07%62.13%